We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
eHealth Stock Rises 45% in a Week: Medicare Boom or AEP Magic?
Read MoreHide Full Article
Shares of eHealth, Inc. (EHTH - Free Report) , an online health insurance marketplace operator, soared 45.1% last week after the company raised its 2024 guidance, citing robust performance during the Annual Enrollment Period (AEP). It witnessed substantial growth in Medicare applications and a record-high number of unassisted online submissions.
eHealth exceeded expectations in telephonic and online conversion rates and leveraged strong consumer demand for its omnichannel platform. The platform connects users to more than 180 health insurers, encompassing both national and regional providers.
Total revenue for 2024 is projected to be in the range of $500-$520 million compared with the prior range of $470-$495 million. This surpasses the Zacks Consensus Estimate of $487.3 million and reflects growth from the 2023 figure of $452.9 million.
Adjusted EBITDA is now expected to be significantly higher, ranging within $40-$55 million compared with the earlier forecast of $7.5-$25 million. The company has also revised its GAAP net income expectations to a range of a $12 million loss to a $3 million profit, an improvement from the previous estimate of a $22-$36.5 million loss.
Operating cash outflow is now expected to fall within $5-$15 million in 2024, slightly higher than the previous guidance of $0 to $10 million. This reflects planned investments to support profitable Medicare enrollment growth in the fourth quarter.
The Zacks Consensus Estimate for 2024 loss per share is pegged at $1.56, indicating a 4.3% improvement from a year ago. The company missed earnings estimates in each of the past four quarters with an average negative surprise of 59.4%. This is depicted in the graph below.
The Zacks Consensus Estimate for Brown & Brown’s 2024 earnings is pegged at $3.74 per share, indicating 33.1% year-over-year growth. Over the past 60 days, BRO has witnessed one upward estimate revision against none in the opposite direction.
The Zacks Consensus Estimate for Assurant’s 2024 earnings is pegged at $15.38 per share, which witnessed three upward estimate revisions in the past 60 days against one opposite movement. Also, the consensus mark for AIZ’s revenues in 2024 suggests a 6% year-over-year rise.
The Zacks Consensus Estimate for CNO Financial’s 2024 bottom line indicates 20.7% year-over-year growth. Over the past 60 days, CNO has witnessed three upward estimate revisions against none in the opposite direction.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
eHealth Stock Rises 45% in a Week: Medicare Boom or AEP Magic?
Shares of eHealth, Inc. (EHTH - Free Report) , an online health insurance marketplace operator, soared 45.1% last week after the company raised its 2024 guidance, citing robust performance during the Annual Enrollment Period (AEP). It witnessed substantial growth in Medicare applications and a record-high number of unassisted online submissions.
eHealth exceeded expectations in telephonic and online conversion rates and leveraged strong consumer demand for its omnichannel platform. The platform connects users to more than 180 health insurers, encompassing both national and regional providers.
eHealth, Inc. Price
eHealth, Inc. price | eHealth, Inc. Quote
Now, let’s focus on its revised guidance.
Total revenue for 2024 is projected to be in the range of $500-$520 million compared with the prior range of $470-$495 million. This surpasses the Zacks Consensus Estimate of $487.3 million and reflects growth from the 2023 figure of $452.9 million.
Adjusted EBITDA is now expected to be significantly higher, ranging within $40-$55 million compared with the earlier forecast of $7.5-$25 million. The company has also revised its GAAP net income expectations to a range of a $12 million loss to a $3 million profit, an improvement from the previous estimate of a $22-$36.5 million loss.
Operating cash outflow is now expected to fall within $5-$15 million in 2024, slightly higher than the previous guidance of $0 to $10 million. This reflects planned investments to support profitable Medicare enrollment growth in the fourth quarter.
The Zacks Consensus Estimate for 2024 loss per share is pegged at $1.56, indicating a 4.3% improvement from a year ago. The company missed earnings estimates in each of the past four quarters with an average negative surprise of 59.4%. This is depicted in the graph below.
eHealth, Inc. Price and EPS Surprise
eHealth, Inc. price-eps-surprise | eHealth, Inc. Quote
Zacks Rank & Key Picks
eHealth currently has a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Finance space are Brown & Brown, Inc. (BRO - Free Report) , Assurant, Inc. (AIZ - Free Report) and CNO Financial Group, Inc. (CNO - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Brown & Brown’s 2024 earnings is pegged at $3.74 per share, indicating 33.1% year-over-year growth. Over the past 60 days, BRO has witnessed one upward estimate revision against none in the opposite direction.
The Zacks Consensus Estimate for Assurant’s 2024 earnings is pegged at $15.38 per share, which witnessed three upward estimate revisions in the past 60 days against one opposite movement. Also, the consensus mark for AIZ’s revenues in 2024 suggests a 6% year-over-year rise.
The Zacks Consensus Estimate for CNO Financial’s 2024 bottom line indicates 20.7% year-over-year growth. Over the past 60 days, CNO has witnessed three upward estimate revisions against none in the opposite direction.